DOI:
10.1055/s-00025476
Endoscopy International Open
LinksClose Window
References
Liang W, Wu X, Fang W. et al.
Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
PLoS One 2014;
9: e85245
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.